Is severe COVID linked to leaky-gut plasma markers?
Severe COVID-19 showed higher tight-junction permeability and bacterial/fungal translocation markers that tracked systemic inflammation; zonulin was higher in patients who later died.
Source
Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients
Study at a glance
- Design
- Cross-sectional — Multi-omic plasma comparison across COVID severity strata plus validation cohort
- N
- N=80 · Main cohort: 60 COVID+ (20 mild/20 moderate/20 severe) + 20 negative controls; markers validated in additional samples
- Population
- Adults with mild–severe COVID-19 and SARS-CoV-2–negative controls (RUMC)
- Outcome
- Plasma gut-permeability and microbial translocation markers vs COVID severity
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
Compared multi-omic plasma profiles from 60 SARS-CoV-2–positive patients (mild/moderate/severe) and 20 negative controls, focusing on gut barrier, translocation, inflammation, metabolome, lipidome, and glycome; key markers validated in an independent cohort.
What they found
Severe disease associated with elevated tight-junction permeability and microbial product translocation markers correlating with inflammation. Plasma zonulin was higher in moderate/severe vs mild/controls and higher among hospitalized patients who died (8/40) vs survivors.
The limits
What it doesn't show
Associations do not prove gut leak causes severe COVID; timing at admission cannot establish sequence, and samples are from selected clinical strata.
Key terms
- Gut permeability
- Impaired intestinal barrier allowing microbial products into blood.
- Zonulin
- Plasma marker linked to tight-junction regulation/permeability.
- Microbial translocation
- Movement of bacterial/fungal products into circulation.
- LBP
- LPS-binding protein reflecting bacterial product exposure.
- sCD14
- Soluble CD14 marker of myeloid activation/translocation.
- Multi-omics
- Combined metabolomic, lipidomic, glycomic, and marker assays.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
ICU-severe group size in main cohort?
Common questions
Main cohort size?
60 COVID+ and 20 controls.
Severity strata?
20 mild, 20 moderate, 20 ICU-severe.
Key permeability marker?
Plasma zonulin elevated in worse disease/death.
Causal?
No—associative multi-omic evidence only.
More on Critical care